What should we know about the person behind a TTO? Floortje van NootenJan BusschbachWerner Brouwer Editorial 18 April 2018 Pages: 1207 - 1211
Preferences for home- and community-based long-term care services in Germany: a discrete choice experiment T. LehnertO. H. GüntherH. H. König Original Research 06 April 2018 Pages: 1213 - 1223
Some adjustments to the human capital and the friction cost methods Antonis Targoutzidis Original Research 21 March 2018 Pages: 1225 - 1228
Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach Ann-Kathrin RichterLudger KlimekJanine Biermann-Stallwitz Original Research 24 March 2018 Pages: 1229 - 1242
The economic impact of multiple sclerosis to the patients and their families in Norway B. SvendsenN. GryttenK-M. Myhr Original Research Open access 21 April 2018 Pages: 1243 - 1257
Tackling the chronic disease burden: are there co-benefits from climate policy measures? Désirée VandenbergheJohan Albrecht Original Research 26 April 2018 Pages: 1259 - 1283
Health inequality indices and exogenous risk factors: an illustration on Luxembourgish workers Stéphane MussardMaria Noel Pi AlperinVéronique Thireau Original Research 03 May 2018 Pages: 1285 - 1301
Cost–utility analysis of an intervention designed to reduce the critical handling error of insufficient inspiratory effort Rebecca ForsterAran RatcliffeWilliam C. N. Dunlop Original Research Open access 12 May 2018 Pages: 1303 - 1318
Cost-effectiveness of enhancing a Quit-and-Win smoking cessation program for college students Jonah PoppJohn A. NymanJanet L. Thomas Original Paper 23 April 2018 Pages: 1319 - 1333
People’s perception and cost-effectiveness of home confinement during an influenza pandemic: evidence from the French case Caroline Orset Original Paper 23 April 2018 Pages: 1335 - 1350
Examining unpriced risk heterogeneity in the Dutch health insurance market A. A. Withagen-KosterR. C. van KleefF. Eijkenaar Original Paper Open access 18 April 2018 Pages: 1351 - 1363
Economic evaluation of Zepatier for the management of HCV in the Italian scenario F. R. RolliM. RuggeriA. Cicchetti Original Paper 25 April 2018 Pages: 1365 - 1374
